Sleep-Wake Neurobiology and Pharmacology
The chapter 'Sleep Physiology, Circadian Rhythms, Waking Performance and the Development of Sleep-Wake Therapeutics' available open access under a CC BY 4.0 license at link.springer.com.
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Cham :
Springer International Publishing : Imprint: Springer,
2019.
|
Έκδοση: | 1st ed. 2019. |
Σειρά: | Handbook of Experimental Pharmacology,
253 |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Part 1.Basic Principles
- 1. The Function(s) of Sleep
- 2. Neuroanatomical and Neurochemical Bases of Vigilance States
- 3. Omics Approaches in Sleep-Wake Regulation
- 4. The Role of Glia in Sleep Regulation and Function
- 5. Sleep- and Wake-Like States in Small 1 Networks In Vivo and In Vitro
- Part 2. Optogenetics and Pharmacogenetics
- 6. Optogenetic Dissection of Sleep-Wake States In Vitro and In Vivo
- 7. Pharmacosynthetic Deconstruction of Sleep-wake Circuits in the Brain
- 8. Clinical and Experimental Human Sleep-Wake Pharmacogenetics
- Part 3. Sleep-Wake Pathologies
- 9. Clinical Sleep-Wake Disorders I: Focus on Hypersomnias and Movement Disorders During Sleep
- 10. Clinical Sleep-Wake Disorders II: Focus on Insomnia and Circadian Rhythm Sleep Disorders
- Part 4. Current and New Targets, and Therapeutic Prospects
- 11. GABA Receptors and the Pharmacology of Sleep
- 12. Advances of Melatonin-Based Therapies in the Treatment of Disturbed Sleep and Mood
- 13. Dopamine and Wakefulness: Pharmacology, Genetics, and Circuitry
- 14. Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood
- 15. Adenosine and Sleep
- Part 5. Outlook
- 16. Adenosine and Sleep
- 17. Functional Interactions Between Sleep and Circadian Rhythms in Learning and Learning Disabilities
- 18. Sleep Physiology, circadian rhythms, Waking Performance and the Development of Sleep-Wake Therapeutics.